Axsome Therapeutics, Inc. — All Filings
616 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000783 | Mar 26, 2026 | — |
| 4 | 4 | 0001193125-26-083605 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-083587 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-083607 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-083608 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-083609 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-083586 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | 4 | 0001193125-26-083606 | Feb 27, 2026 | Feb 26, 2026 |
| 144 | — | 0001958244-26-000103 | Feb 26, 2026 | — |
| 144 | — | 0001921094-26-000210 | Feb 26, 2026 | — |
| 4 | 4 | 0001193125-26-072481 | Feb 25, 2026 | Feb 23, 2026 |
| 4 | 4 | 0001193125-26-064681 | Feb 23, 2026 | Feb 20, 2026 |
| 10-K | 10-K | 0001193125-26-064267 | Feb 23, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-062421 | Feb 23, 2026 | — |
| 8-K | 8-K | 0001193125-26-053009 | Feb 17, 2026 | — |
| 4 | 4 | 0001193125-26-045110 | Feb 10, 2026 | — |
| 144 | — | 0001958244-26-000063 | Feb 2, 2026 | — |
| 4 | 4 | 0001193125-26-033973 | Feb 2, 2026 | — |
| 4 | 4 | 0001193125-26-021377 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | 4 | 0001193125-26-021378 | Jan 23, 2026 | Jan 22, 2026 |
| 144 | — | 0001921094-26-000055 | Jan 22, 2026 | — |
| 144 | — | 0001921094-26-000051 | Jan 21, 2026 | — |
| 8-K | 8-K | 0001193125-26-009744 | Jan 12, 2026 | — |
| 144 | — | 0001958244-26-000028 | Jan 7, 2026 | — |
| 4 | 4 | 0001193125-26-006695 | Jan 7, 2026 | Jan 5, 2026 |
| 144 | — | 0001958244-26-000021 | Jan 6, 2026 | — |
| 144 | — | 0001958244-26-000014 | Jan 5, 2026 | — |
| 4 | 4 | 0001193125-26-001181 | Jan 2, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-25-337644 | Dec 31, 2025 | — |
| 144 | — | 0001921094-25-001592 | Dec 31, 2025 | — |
| 4 | 4 | 0001193125-25-308354 | Dec 4, 2025 | Dec 2, 2025 |
| 144 | — | 0001958244-25-004519 | Dec 4, 2025 | — |
| 144 | — | 0001958244-25-004511 | Dec 3, 2025 | — |
| 144 | — | 0001958244-25-004504 | Dec 2, 2025 | — |
| 4 | 4 | 0001193125-25-267467 | Nov 5, 2025 | Nov 3, 2025 |
| 144 | — | 0001958244-25-004438 | Nov 5, 2025 | — |
| 144 | — | 0001958244-25-004433 | Nov 4, 2025 | — |
| 144 | — | 0001958244-25-004427 | Nov 3, 2025 | — |
| 8-K | 8-K | 0001193125-25-261651 | Nov 3, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-262664 | Nov 3, 2025 | Sep 30, 2025 |
| S-3ASR | S-3ASR | 0001193125-25-262696 | Nov 3, 2025 | — |
| 144 | — | 0001958244-25-004387 | Oct 8, 2025 | — |
| 4 | 4 | 0001193125-25-234881 | Oct 8, 2025 | Oct 6, 2025 |
| 144 | — | 0001958244-25-004383 | Oct 7, 2025 | — |
| 144 | — | 0001958244-25-004372 | Oct 6, 2025 | — |
| 144 | — | 0001921094-25-001190 | Sep 22, 2025 | — |
| 4 | 4 | 0001193125-25-211788 | Sep 22, 2025 | — |
| 4 | 4 | 0001193125-25-206494 | Sep 17, 2025 | Sep 16, 2025 |
| 4 | 4 | 0001193125-25-205260 | Sep 16, 2025 | Sep 12, 2025 |
| 144 | — | 0001921094-25-001167 | Sep 16, 2025 | — |